Department of Mathematical Modelling, Ghent University, Ghent, Belgium.
Arterioscler Thromb Vasc Biol. 2012 Dec;32(12):3076-81. doi: 10.1161/ATVBAHA.112.300341. Epub 2012 Oct 18.
Shorter telomere length is associated with the occurrence of cardiovascular events, but the question of causality is complicated by the intertwined effects of inheritance, aging, and lifestyle factors on both telomere length and cardiovascular disease (CVD). Some studies indicated that healthy offspring of coronary artery disease patients exhibited shorter telomeres than subjects without a family history. Importantly, this result would imply that inheritance of shorter telomeres is a primary abnormality associated with an increased risk of CVD, the so-called Telomere Hypothesis of CVD. Therefore, we aimed at further validating the latter results in the large, population-representative Asklepios Study.
Peripheral blood leukocyte telomere length was measured using telomere restriction fragment analysis in the young to middle-aged (≈ 35-55 years old) Asklepios study population, free from overt CVD, and could be successfully combined with data from the Asklepios Family History Database for 2136 subjects. No shorter telomere length could be found in healthy subjects with a family history of CVD compared with those without.
These findings cast serious doubt on the hypothesis that telomere length is shorter in families with an increased risk of CVD and do not support the Telomere Hypothesis of CVD.
端粒较短与心血管事件的发生有关,但由于遗传、衰老和生活方式因素对端粒长度和心血管疾病(CVD)都有相互影响,因此因果关系较为复杂。一些研究表明,冠心病患者的健康后代的端粒比没有家族病史的人短。重要的是,这一结果意味着较短的端粒遗传是与 CVD 风险增加相关的主要异常,即所谓的 CVD 端粒假说。因此,我们旨在通过大型的、具有代表性的 Asklepios 研究进一步验证后者的结果。
使用端粒限制片段分析测量了年轻到中年(约 35-55 岁)Asklepios 研究人群的外周血白细胞端粒长度,这些人没有明显的 CVD,可以与 Asklepios 家族病史数据库中的 2136 名受试者的数据成功结合。与没有家族病史的人相比,有 CVD 家族史的健康受试者的端粒长度并没有更短。
这些发现严重怀疑端粒长度在 CVD 风险增加的家族中较短的假设,并且不支持 CVD 端粒假说。